Competent Cells Market by Type (Chemically, Electrocompetent), Application (Subcloning, Phage Display Library Production, Unstable DNA Cloning, High-Throughput Cloning, Mutagenesis), End User (Pharmaceutical Companies, Academia) - Global Forecast to 2022
The global competent cells market is projected to reach USD 2.22 billion by 2022 from USD 1.37 billion in 2017, at a CAGR of 10.2%. Advancements in molecular cloning research due to the emergence of new technologies and the growing commercial demand for molecular cloned products and recombinant proteins are some the key factors driving the growth of this market. On the other hand, increasing market consolidation creating strong entry barriers and high cost of competent cells kits are restraining the growth of this market.
The electrocompetent cells segment is expected to register the highest CAGR during the forecast period
The competent cells market is classified on the basis of type into chemically competent cells and electrocompetent cells. Electrocompetent cells are expected to grow at the highest CAGR during the forecast period. Electrocompetent cells offer high transformation efficiencies, making them suitable for many molecular biology applications such as the generation of cDNA libraries or constructing gene banks.
Increasing intensity of research and technological advancements drives growth of the other applications segment
Based on application, the global competent cells market is broadly segmented into cloning, protein expression, and other applications. The other applications segment is expected to register the highest CAGR during the forecast period. This segment comprises of mutagenesis, single-stranded DNA production, lentiviral vector production, and large plasmid transformation. The growth in this segment is primarily attributed to increasing intensity of research and technological advancements.
Pharmaceutical & biotechnology companies segment is expected to witness the highest growth
The competent cells market is classified on the basis of end users into academic research institutes, contract research organizations (CROs), and pharmaceutical & biotechnology companies. Pharmaceutical & biotechnology companies are expected to grow at the highest CAGR during the forecast period. This is primarily due to the rising investments in research for developing genomics and proteomics-based products.
North America to account for the largest share of the market
Geographically, the competent cells market is dominated by North America, followed by Europe. The North American region is estimated to account for the largest share in 2017, and the trend is expected to continue during the forecast period. The growth in this market can be attributed to the presence of major key players in the region, technological advancements, growth in the biotechnology and pharmaceutical industries, and increasing inclination towards research based on genomics and proteomics.
The primary interviews conducted for this report can be categorized as follows:
Study Coverage:
The report analyses the competent cells market by type, application, end user, and region. Apart from comprehensive geographic and product analysis and market sizing, the report also provides the competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the report profiles companies with product portfolios, developments, and strategies adopted by key players to maintain and increase their shares in the market. The above-mentioned market research data, market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions to be successful in the market.
Benefits of Buying this Report:
This report will enable both established firms as well as new entrants/smaller firms gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the five strategies mentioned below to strengthen their market shares.
The report provides insights on the following strategies:
The electrocompetent cells segment is expected to register the highest CAGR during the forecast period
The competent cells market is classified on the basis of type into chemically competent cells and electrocompetent cells. Electrocompetent cells are expected to grow at the highest CAGR during the forecast period. Electrocompetent cells offer high transformation efficiencies, making them suitable for many molecular biology applications such as the generation of cDNA libraries or constructing gene banks.
Increasing intensity of research and technological advancements drives growth of the other applications segment
Based on application, the global competent cells market is broadly segmented into cloning, protein expression, and other applications. The other applications segment is expected to register the highest CAGR during the forecast period. This segment comprises of mutagenesis, single-stranded DNA production, lentiviral vector production, and large plasmid transformation. The growth in this segment is primarily attributed to increasing intensity of research and technological advancements.
Pharmaceutical & biotechnology companies segment is expected to witness the highest growth
The competent cells market is classified on the basis of end users into academic research institutes, contract research organizations (CROs), and pharmaceutical & biotechnology companies. Pharmaceutical & biotechnology companies are expected to grow at the highest CAGR during the forecast period. This is primarily due to the rising investments in research for developing genomics and proteomics-based products.
North America to account for the largest share of the market
Geographically, the competent cells market is dominated by North America, followed by Europe. The North American region is estimated to account for the largest share in 2017, and the trend is expected to continue during the forecast period. The growth in this market can be attributed to the presence of major key players in the region, technological advancements, growth in the biotechnology and pharmaceutical industries, and increasing inclination towards research based on genomics and proteomics.
The primary interviews conducted for this report can be categorized as follows:
- By Company Type - Tier 1 – 25 %, Tier 2 – 35% and Tier 3 – 40%
- By Designation – C-level – 35%, Director-level – 25%, Others – 40%
- By Region – North America - 43%, Europe – 19%, APAC – 29%, RoW – 9%
Study Coverage:
The report analyses the competent cells market by type, application, end user, and region. Apart from comprehensive geographic and product analysis and market sizing, the report also provides the competitive landscape that covers the growth strategies adopted by industry players over the last three years. In addition, the report profiles companies with product portfolios, developments, and strategies adopted by key players to maintain and increase their shares in the market. The above-mentioned market research data, market size, and forecast of the future trends will help key market players and new entrants to make the necessary decisions to be successful in the market.
Benefits of Buying this Report:
This report will enable both established firms as well as new entrants/smaller firms gauge the pulse of the market, which in turn will help these firms garner greater market shares. Firms purchasing the report can use any one or a combination of the five strategies mentioned below to strengthen their market shares.
The report provides insights on the following strategies:
- Market Penetration: Comprehensive information on the product portfolios of the top players in the competent cells market. The report analyzes the competent cells market by type, application, and end user
- Competitive Assessment: In-depth assessment of the market strategies, geographic and business segments, and product portfolios of the leading players in the competent cells market
- Market Development: Comprehensive information about emerging markets. This report analyzes the market for various competent cell products across geographies
- Market Diversification: Exhaustive information about new products, untapped geographies, recent developments, and investments in the competent cells market
1 INTRODUCTION
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 MARKET SIZE ESTIMATION
2.2 DATA TRIANGULATION
2.3 MARKET SHARE ESTIMATION
2.3.1 KEY DATA FROM SECONDARY SOURCES
2.3.2 KEY DATA FROM PRIMARY SOURCES
2.3.3 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 COMPETENT CELLS: MARKET OVERVIEW
4.2 COMPETENT CELLS MARKET, BY CLONING APPLICATION (2017)
4.3 GEOGRAPHICAL SNAPSHOT OF THE COMPETENT CELLS MARKET
4.4 COMPETENT CELLS MARKET, BY APPLICATION, 2017 VS. 2022
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Advancements in molecular cloning research due to the emergence of new technologies
5.2.1.2 Growing commercial demand for molecular cloned products and recombinant proteins
5.2.2 RESTRAINTS
5.2.2.1 High cost of competent cell kits
5.2.2.2 Increasing market consolidation creating strong entry barriers
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging markets
5.2.3.2 Emerging applications of competent cells
5.2.4 CHALLENGES
5.2.4.1 Lack of skilled professionals
6 COMPETENT CELLS MARKET, BY TYPE
6.1 INTRODUCTION
6.2 CHEMICALLY COMPETENT CELLS
6.3 ELECTROCOMPETENT CELLS
7 COMPETENT CELLS MARKET, BY APPLICATION
7.1 INTRODUCTION
7.2 CLONING
7.2.1 SUBCLONING & ROUTINE CLONING
7.2.2 PHAGE DISPLAY LIBRARY CONSTRUCTION
7.2.3 TOXIC/UNSTable DNA CLONING
7.2.4 HIGH-THROUGHPUT CLONING
7.3 PROTEIN EXPRESSION
7.4 OTHER APPLICATIONS
7.4.1 MUTAGENESIS
7.4.2 LARGE PLASMID TRANSFORMATION
7.4.3 SINGLE-STRANDED DNA PRODUCTION
7.4.4 LENTIVIRAL VECTOR PRODUCTION
8 COMPETENT CELLS MARKET, BY END USER
8.1 INTRODUCTION
8.2 ACADEMIC RESEARCH INSTITUTES
8.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
8.4 CONTRACT RESEARCH ORGANIZATIONS
9 COMPETENT CELLS MARKET, BY REGION
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 U.S.
9.2.2 CANADA
9.3 EUROPE
9.3.1 GERMANY
9.3.2 U.K.
9.3.3 FRANCE
9.3.4 REST OF EUROPE
9.4 ASIA-PACIFIC
9.4.1 JAPAN
9.4.2 AUSTRALIA
9.4.3 CHINA
9.4.4 INDIA
9.4.5 REST OF APAC
9.5 REST OF THE WORLD (ROW)
10 COMPETITIVE LANDSCAPE
10.1 INTRODUCTION
10.2 MARKET SHARE ANALYSIS
10.3 COMPETITIVE LEADERSHIP MAPPING
10.3.1 VISIONARY LEADERS
10.3.2 INNOVATORS
10.3.3 DYNAMIC DIFFERENTIATORS
10.3.4 EMERGING COMPANIES
10.4 COMPETITIVE BENCHMARKING
10.4.1 BUSINESS STRATEGY EXCELLENCE (FOR 25 PLAYERS)
10.4.2 STRENGTH OF PRODUCT PORTFOLIO (FOR 25 PLAYERS)
*Top 25 companies analysed for this study are - Merck KGaA (Germany), Promega Corporation (U.S.), Thermo Fisher Scientific Inc. (U.S), New England Biolabs (U.S.), Takara Bio (Japan), Agilent Technologies (U.S.), Lucigen (Epicenter) (Illumina) (U.S.), QIAGEN N.V. (Germany), OriGene Technologies (U.S.), Bioline (U.K.), Zymo Research (U.S.), Beijing TransGen Biotech Co., Ltd. (China), Source BioScience (U.K.), IBA GmBH (Germany), Genewiz (U.S.), BioDynamics Laboratory Inc. (Japan), GCC Biotech (India), SMOBIO Technology (Taiwan), GeneScript Corporation (U.S.), Bio-Rad Laboratories (U.S.), Life Technologies (India) Pvt. Ltd., Cell Applications, Inc. (U.S.), Delphi Genetics (Belgium), Scarab Genomics LLC (U.S.), and Yeastern Biotech Co. Ltd. (Taiwan).
11 COMPANY PROFILES
(Overview, Strength of Product Portfolio Business Strategy Excellence Products Offering, Recent Development’s, Business Strategy)*
11.1 THERMO FISHER SCIENTIFIC INC.
11.2 MERCK KGAA
11.3 PROMEGA CORPORATION
11.4 TAKARA BIO INC.
11.5 NEW ENGLAND BIOLABS INC.
11.6 BIO-RAD LABORATORIES, INC.
11.7 TRANSGEN BIOTECH, INC.
11.8 AGILENT TECHNOLOGIES, INC.
11.9 ILLUMINA, INC.
11.10 ZYMO RESEARCH
11.11 QIAGEN N.V.
11.12 GENSCRIPT BIOTECH CORPORATION
11.13 ORIGENE TECHNOLOGIES, INC.
*Details on Overview, Strength of Product Portfolio Business Strategy Excellence Products Offering, Recent Development’s, Business Strategy might not be captured in case of unlisted companies.
12 APPENDIX
12.1 INDUSTRY INSIGHTS
12.2 DISCUSSION GUIDE
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
12.5 AVAILABLE CUSTOMIZATIONS
12.6 RELATED REPORTS
12.7 AUTHOR DETAILS
1.1 OBJECTIVES OF THE STUDY
1.2 MARKET DEFINITION
1.3 MARKET SCOPE
1.3.1 MARKETS COVERED
1.3.2 YEARS CONSIDERED FOR THE STUDY
1.4 CURRENCY
1.5 LIMITATIONS
1.6 STAKEHOLDERS
2 RESEARCH METHODOLOGY
2.1 MARKET SIZE ESTIMATION
2.2 DATA TRIANGULATION
2.3 MARKET SHARE ESTIMATION
2.3.1 KEY DATA FROM SECONDARY SOURCES
2.3.2 KEY DATA FROM PRIMARY SOURCES
2.3.3 ASSUMPTIONS FOR THE STUDY
3 EXECUTIVE SUMMARY
4 PREMIUM INSIGHTS
4.1 COMPETENT CELLS: MARKET OVERVIEW
4.2 COMPETENT CELLS MARKET, BY CLONING APPLICATION (2017)
4.3 GEOGRAPHICAL SNAPSHOT OF THE COMPETENT CELLS MARKET
4.4 COMPETENT CELLS MARKET, BY APPLICATION, 2017 VS. 2022
5 MARKET OVERVIEW
5.1 INTRODUCTION
5.2 MARKET DYNAMICS
5.2.1 DRIVERS
5.2.1.1 Advancements in molecular cloning research due to the emergence of new technologies
5.2.1.2 Growing commercial demand for molecular cloned products and recombinant proteins
5.2.2 RESTRAINTS
5.2.2.1 High cost of competent cell kits
5.2.2.2 Increasing market consolidation creating strong entry barriers
5.2.3 OPPORTUNITIES
5.2.3.1 Emerging markets
5.2.3.2 Emerging applications of competent cells
5.2.4 CHALLENGES
5.2.4.1 Lack of skilled professionals
6 COMPETENT CELLS MARKET, BY TYPE
6.1 INTRODUCTION
6.2 CHEMICALLY COMPETENT CELLS
6.3 ELECTROCOMPETENT CELLS
7 COMPETENT CELLS MARKET, BY APPLICATION
7.1 INTRODUCTION
7.2 CLONING
7.2.1 SUBCLONING & ROUTINE CLONING
7.2.2 PHAGE DISPLAY LIBRARY CONSTRUCTION
7.2.3 TOXIC/UNSTable DNA CLONING
7.2.4 HIGH-THROUGHPUT CLONING
7.3 PROTEIN EXPRESSION
7.4 OTHER APPLICATIONS
7.4.1 MUTAGENESIS
7.4.2 LARGE PLASMID TRANSFORMATION
7.4.3 SINGLE-STRANDED DNA PRODUCTION
7.4.4 LENTIVIRAL VECTOR PRODUCTION
8 COMPETENT CELLS MARKET, BY END USER
8.1 INTRODUCTION
8.2 ACADEMIC RESEARCH INSTITUTES
8.3 PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES
8.4 CONTRACT RESEARCH ORGANIZATIONS
9 COMPETENT CELLS MARKET, BY REGION
9.1 INTRODUCTION
9.2 NORTH AMERICA
9.2.1 U.S.
9.2.2 CANADA
9.3 EUROPE
9.3.1 GERMANY
9.3.2 U.K.
9.3.3 FRANCE
9.3.4 REST OF EUROPE
9.4 ASIA-PACIFIC
9.4.1 JAPAN
9.4.2 AUSTRALIA
9.4.3 CHINA
9.4.4 INDIA
9.4.5 REST OF APAC
9.5 REST OF THE WORLD (ROW)
10 COMPETITIVE LANDSCAPE
10.1 INTRODUCTION
10.2 MARKET SHARE ANALYSIS
10.3 COMPETITIVE LEADERSHIP MAPPING
10.3.1 VISIONARY LEADERS
10.3.2 INNOVATORS
10.3.3 DYNAMIC DIFFERENTIATORS
10.3.4 EMERGING COMPANIES
10.4 COMPETITIVE BENCHMARKING
10.4.1 BUSINESS STRATEGY EXCELLENCE (FOR 25 PLAYERS)
10.4.2 STRENGTH OF PRODUCT PORTFOLIO (FOR 25 PLAYERS)
*Top 25 companies analysed for this study are - Merck KGaA (Germany), Promega Corporation (U.S.), Thermo Fisher Scientific Inc. (U.S), New England Biolabs (U.S.), Takara Bio (Japan), Agilent Technologies (U.S.), Lucigen (Epicenter) (Illumina) (U.S.), QIAGEN N.V. (Germany), OriGene Technologies (U.S.), Bioline (U.K.), Zymo Research (U.S.), Beijing TransGen Biotech Co., Ltd. (China), Source BioScience (U.K.), IBA GmBH (Germany), Genewiz (U.S.), BioDynamics Laboratory Inc. (Japan), GCC Biotech (India), SMOBIO Technology (Taiwan), GeneScript Corporation (U.S.), Bio-Rad Laboratories (U.S.), Life Technologies (India) Pvt. Ltd., Cell Applications, Inc. (U.S.), Delphi Genetics (Belgium), Scarab Genomics LLC (U.S.), and Yeastern Biotech Co. Ltd. (Taiwan).
11 COMPANY PROFILES
(Overview, Strength of Product Portfolio Business Strategy Excellence Products Offering, Recent Development’s, Business Strategy)*
11.1 THERMO FISHER SCIENTIFIC INC.
11.2 MERCK KGAA
11.3 PROMEGA CORPORATION
11.4 TAKARA BIO INC.
11.5 NEW ENGLAND BIOLABS INC.
11.6 BIO-RAD LABORATORIES, INC.
11.7 TRANSGEN BIOTECH, INC.
11.8 AGILENT TECHNOLOGIES, INC.
11.9 ILLUMINA, INC.
11.10 ZYMO RESEARCH
11.11 QIAGEN N.V.
11.12 GENSCRIPT BIOTECH CORPORATION
11.13 ORIGENE TECHNOLOGIES, INC.
*Details on Overview, Strength of Product Portfolio Business Strategy Excellence Products Offering, Recent Development’s, Business Strategy might not be captured in case of unlisted companies.
12 APPENDIX
12.1 INDUSTRY INSIGHTS
12.2 DISCUSSION GUIDE
12.3 KNOWLEDGE STORE: MARKETSANDMARKETS’ SUBSCRIPTION PORTAL
12.4 INTRODUCING RT: REAL-TIME MARKET INTELLIGENCE
12.5 AVAILABLE CUSTOMIZATIONS
12.6 RELATED REPORTS
12.7 AUTHOR DETAILS
LIST OF TABLES
Table 1 COMPETENT CELLS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 2 CHEMICALLY COMPETENT CELLS MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 3 ELECTROCOMPETENT CELLS MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 4 COMPETENT CELLS MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 5 COMPETENT CELLS MARKET FOR CLONING APPLICATIONS, BY REGION, 2015–2022 (USD MILLION)
Table 6 COMPETENT CELLS MARKET FOR CLONING APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION)
Table 7 COMPETENT CELLS MARKET FOR SUBCLONING & ROUTINE CLONING, BY REGION, 2015–2022 (USD MILLION)
Table 8 COMPETENT CELLS MARKET FOR PHAGE DISPLAY LIBRARY CONSTRUCTION, BY REGION, 2015–2022 (USD MILLION)
Table 9 COMPETENT CELLS MARKET FOR TOXIC/UNSTable DNA CLONING, BY REGION, 2015–2022 (USD MILLION)
Table 10 COMPETENT CELLS MARKET FOR HIGH-THROUGHPUT CLONING, BY REGION, 2015–2022 (USD MILLION)
Table 11 COMPETENT CELLS MARKET FOR PROTEIN EXPRESSION APPLICATIONS, BY REGION, 2015–2022 (USD MILLION)
Table 12 COMPETENT CELLS MARKET FOR OTHER APPLICATIONS, BY REGION, 2015–2022 (USD MILLION)
Table 13 COMPETENT CELLS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION)
Table 14 COMPETENT CELLS MARKET FOR MUTAGENESIS, BY REGION, 2015–2022 (USD MILLION)
Table 15 COMPETENT CELLS MARKET FOR LARGE PLASMID TRANSFORMATION, BY REGION, 2015–2022 (USD MILLION)
Table 16 COMPETENT CELLS MARKET FOR SINGLE-STRANDED DNA PRODUCTION, BY REGION, 2015–2022 (USD MILLION)
Table 17 COMPETENT CELLS MARKET FOR LENTIVIRAL VECTOR PRODUCTION, BY REGION, 2015–2022 (USD MILLION)
Table 18 COMPETENT CELLS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 19 U.S. R&D PERFORMANCE, 2015
Table 20 COMPETENT CELLS MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2015–2022 (USD MILLION)
Table 21 COMPETENT CELLS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2015–2022 (USD MILLION)
Table 22 COMPETENT CELLS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2015–2022 (USD MILLION)
Table 23 COMPETENT CELLS MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 24 NORTH AMERICA: COMPETENT CELLS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 25 NORTH AMERICA: COMPETENT CELLS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 26 NORTH AMERICA: COMPETENT CELLS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
Table 27 NORTH AMERICA: COMPETENT CELLS MARKET FOR CLONING APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION)
Table 28 NORTH AMERICA: COMPETENT CELLS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION)
Table 29 NORTH AMERICA: COMPETENT CELLS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 30 U.S.: COMPETENT CELLS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 31 U.S.: COMPETENT CELLS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
Table 32 U.S.: COMPETENT CELLS MARKET FOR CLONING APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION)
Table 33 U.S.: COMPETENT CELLS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION)
Table 34 U.S.: COMPETENT CELLS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 35 CANADA: COMPETENT CELLS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 36 CANADA: COMPETENT CELLS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
Table 37 CANADA: COMPETENT CELLS MARKET FOR CLONING APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION)
Table 38 CANADA: COMPETENT CELLS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION)
Table 39 CANADA: COMPETENT CELLS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 40 EUROPE: COMPETENT CELLS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 41 EUROPE: COMPETENT CELLS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 42 EUROPE: COMPETENT CELLS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
Table 43 EUROPE: COMPETENT CELLS MARKET FOR CLONING APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION)
Table 44 EUROPE: COMPETENT CELLS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION)
Table 45 EUROPE: COMPETENT CELLS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 46 GERMANY: COMPETENT CELLS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 47 GERMANY: COMPETENT CELLS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
Table 48 GERMANY: COMPETENT CELLS MARKET FOR CLONING APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION)
Table 49 GERMANY: COMPETENT CELLS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION)
Table 50 GERMANY: COMPETENT CELLS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 51 U.K.: COMPETENT CELLS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 52 U.K.: COMPETENT CELLS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
Table 53 U.K.: COMPETENT CELLS MARKET FOR CLONING APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION)
Table 54 U.K.: COMPETENT CELLS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION)
Table 55 U.K.: COMPETENT CELLS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 56 FRANCE: COMPETENT CELLS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 57 FRANCE: COMPETENT CELLS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
Table 58 FRANCE: COMPETENT CELLS MARKET FOR CLONING APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION)
Table 59 FRANCE: COMPETENT CELLS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION)
Table 60 FRANCE: COMPETENT CELLS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 61 ROE: COMPETENT CELLS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 62 ROE: COMPETENT CELLS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
Table 63 ROE: COMPETENT CELLS MARKET FOR CLONING APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION)
Table 64 ROE: COMPETENT CELLS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION)
Table 65 ROE: COMPETENT CELLS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 66 ASIA-PACIFIC: COMPETENT CELLS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 67 ASIA-PACIFIC: COMPETENT CELLS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 68 ASIA-PACIFIC: COMPETENT CELLS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
Table 69 ASIA-PACIFIC: COMPETENT CELLS MARKET FOR CLONING APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION)
Table 70 ASIA-PACIFIC: COMPETENT CELLS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION)
Table 71 ASIA-PACIFIC: COMPETENT CELLS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 72 JAPAN: COMPETENT CELLS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 73 JAPAN: COMPETENT CELLS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
Table 74 JAPAN: COMPETENT CELLS MARKET FOR CLONING APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION)
Table 75 JAPAN: COMPETENT CELLS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION)
Table 76 JAPAN: COMPETENT CELLS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 77 AUSTRALIA: COMPETENT CELLS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 78 AUSTRALIA: COMPETENT CELLS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
Table 79 AUSTRALIA: COMPETENT CELLS MARKET FOR CLONING APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION)
Table 80 AUSTRALIA: COMPETENT CELLS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION)
Table 81 AUSTRALIA: COMPETENT CELLS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 82 CHINA: COMPETENT CELLS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 83 CHINA: COMPETENT CELLS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
Table 84 CHINA: COMPETENT CELLS MARKET FOR CLONING APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION)
Table 85 CHINA: COMPETENT CELLS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION)
Table 86 CHINA: COMPETENT CELLS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 87 INDIA: COMPETENT CELLS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 88 INDIA: COMPETENT CELLS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
Table 89 INDIA: COMPETENT CELLS MARKET FOR CLONING APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION)
Table 90 INDIA: COMPETENT CELLS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION)
Table 91 INDIA: COMPETENT CELLS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 92 REST OF APAC: COMPETENT CELLS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 93 REST OF APAC: COMPETENT CELLS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
Table 94 REST OF APAC: COMPETENT CELLS MARKET FOR CLONING APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION)
Table 95 REST OF APAC: COMPETENT CELLS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION)
Table 96 REST OF APAC: COMPETENT CELLS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 97 ROW: COMPETENT CELLS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 98 ROW: COMPETENT CELLS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
Table 99 ROW: COMPETENT CELLS MARKET FOR CLONING APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION)
Table 100 ROW: COMPETENT CELLS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION)
Table 101 ROW: COMPETENT CELLS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 1 COMPETENT CELLS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 2 CHEMICALLY COMPETENT CELLS MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 3 ELECTROCOMPETENT CELLS MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 4 COMPETENT CELLS MARKET SIZE, BY APPLICATION, 2015–2022 (USD MILLION)
Table 5 COMPETENT CELLS MARKET FOR CLONING APPLICATIONS, BY REGION, 2015–2022 (USD MILLION)
Table 6 COMPETENT CELLS MARKET FOR CLONING APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION)
Table 7 COMPETENT CELLS MARKET FOR SUBCLONING & ROUTINE CLONING, BY REGION, 2015–2022 (USD MILLION)
Table 8 COMPETENT CELLS MARKET FOR PHAGE DISPLAY LIBRARY CONSTRUCTION, BY REGION, 2015–2022 (USD MILLION)
Table 9 COMPETENT CELLS MARKET FOR TOXIC/UNSTable DNA CLONING, BY REGION, 2015–2022 (USD MILLION)
Table 10 COMPETENT CELLS MARKET FOR HIGH-THROUGHPUT CLONING, BY REGION, 2015–2022 (USD MILLION)
Table 11 COMPETENT CELLS MARKET FOR PROTEIN EXPRESSION APPLICATIONS, BY REGION, 2015–2022 (USD MILLION)
Table 12 COMPETENT CELLS MARKET FOR OTHER APPLICATIONS, BY REGION, 2015–2022 (USD MILLION)
Table 13 COMPETENT CELLS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION)
Table 14 COMPETENT CELLS MARKET FOR MUTAGENESIS, BY REGION, 2015–2022 (USD MILLION)
Table 15 COMPETENT CELLS MARKET FOR LARGE PLASMID TRANSFORMATION, BY REGION, 2015–2022 (USD MILLION)
Table 16 COMPETENT CELLS MARKET FOR SINGLE-STRANDED DNA PRODUCTION, BY REGION, 2015–2022 (USD MILLION)
Table 17 COMPETENT CELLS MARKET FOR LENTIVIRAL VECTOR PRODUCTION, BY REGION, 2015–2022 (USD MILLION)
Table 18 COMPETENT CELLS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 19 U.S. R&D PERFORMANCE, 2015
Table 20 COMPETENT CELLS MARKET FOR ACADEMIC RESEARCH INSTITUTES, BY REGION, 2015–2022 (USD MILLION)
Table 21 COMPETENT CELLS MARKET FOR PHARMACEUTICAL & BIOTECHNOLOGY COMPANIES, BY REGION, 2015–2022 (USD MILLION)
Table 22 COMPETENT CELLS MARKET FOR CONTRACT RESEARCH ORGANIZATIONS, BY REGION, 2015–2022 (USD MILLION)
Table 23 COMPETENT CELLS MARKET, BY REGION, 2015–2022 (USD MILLION)
Table 24 NORTH AMERICA: COMPETENT CELLS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 25 NORTH AMERICA: COMPETENT CELLS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 26 NORTH AMERICA: COMPETENT CELLS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
Table 27 NORTH AMERICA: COMPETENT CELLS MARKET FOR CLONING APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION)
Table 28 NORTH AMERICA: COMPETENT CELLS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION)
Table 29 NORTH AMERICA: COMPETENT CELLS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 30 U.S.: COMPETENT CELLS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 31 U.S.: COMPETENT CELLS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
Table 32 U.S.: COMPETENT CELLS MARKET FOR CLONING APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION)
Table 33 U.S.: COMPETENT CELLS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION)
Table 34 U.S.: COMPETENT CELLS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 35 CANADA: COMPETENT CELLS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 36 CANADA: COMPETENT CELLS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
Table 37 CANADA: COMPETENT CELLS MARKET FOR CLONING APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION)
Table 38 CANADA: COMPETENT CELLS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION)
Table 39 CANADA: COMPETENT CELLS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 40 EUROPE: COMPETENT CELLS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 41 EUROPE: COMPETENT CELLS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 42 EUROPE: COMPETENT CELLS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
Table 43 EUROPE: COMPETENT CELLS MARKET FOR CLONING APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION)
Table 44 EUROPE: COMPETENT CELLS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION)
Table 45 EUROPE: COMPETENT CELLS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 46 GERMANY: COMPETENT CELLS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 47 GERMANY: COMPETENT CELLS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
Table 48 GERMANY: COMPETENT CELLS MARKET FOR CLONING APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION)
Table 49 GERMANY: COMPETENT CELLS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION)
Table 50 GERMANY: COMPETENT CELLS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 51 U.K.: COMPETENT CELLS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 52 U.K.: COMPETENT CELLS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
Table 53 U.K.: COMPETENT CELLS MARKET FOR CLONING APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION)
Table 54 U.K.: COMPETENT CELLS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION)
Table 55 U.K.: COMPETENT CELLS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 56 FRANCE: COMPETENT CELLS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 57 FRANCE: COMPETENT CELLS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
Table 58 FRANCE: COMPETENT CELLS MARKET FOR CLONING APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION)
Table 59 FRANCE: COMPETENT CELLS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION)
Table 60 FRANCE: COMPETENT CELLS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 61 ROE: COMPETENT CELLS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 62 ROE: COMPETENT CELLS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
Table 63 ROE: COMPETENT CELLS MARKET FOR CLONING APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION)
Table 64 ROE: COMPETENT CELLS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION)
Table 65 ROE: COMPETENT CELLS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 66 ASIA-PACIFIC: COMPETENT CELLS MARKET, BY COUNTRY, 2015–2022 (USD MILLION)
Table 67 ASIA-PACIFIC: COMPETENT CELLS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 68 ASIA-PACIFIC: COMPETENT CELLS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
Table 69 ASIA-PACIFIC: COMPETENT CELLS MARKET FOR CLONING APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION)
Table 70 ASIA-PACIFIC: COMPETENT CELLS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION)
Table 71 ASIA-PACIFIC: COMPETENT CELLS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 72 JAPAN: COMPETENT CELLS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 73 JAPAN: COMPETENT CELLS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
Table 74 JAPAN: COMPETENT CELLS MARKET FOR CLONING APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION)
Table 75 JAPAN: COMPETENT CELLS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION)
Table 76 JAPAN: COMPETENT CELLS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 77 AUSTRALIA: COMPETENT CELLS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 78 AUSTRALIA: COMPETENT CELLS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
Table 79 AUSTRALIA: COMPETENT CELLS MARKET FOR CLONING APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION)
Table 80 AUSTRALIA: COMPETENT CELLS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION)
Table 81 AUSTRALIA: COMPETENT CELLS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 82 CHINA: COMPETENT CELLS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 83 CHINA: COMPETENT CELLS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
Table 84 CHINA: COMPETENT CELLS MARKET FOR CLONING APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION)
Table 85 CHINA: COMPETENT CELLS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION)
Table 86 CHINA: COMPETENT CELLS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 87 INDIA: COMPETENT CELLS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 88 INDIA: COMPETENT CELLS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
Table 89 INDIA: COMPETENT CELLS MARKET FOR CLONING APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION)
Table 90 INDIA: COMPETENT CELLS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION)
Table 91 INDIA: COMPETENT CELLS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 92 REST OF APAC: COMPETENT CELLS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 93 REST OF APAC: COMPETENT CELLS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
Table 94 REST OF APAC: COMPETENT CELLS MARKET FOR CLONING APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION)
Table 95 REST OF APAC: COMPETENT CELLS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION)
Table 96 REST OF APAC: COMPETENT CELLS MARKET, BY END USER, 2015–2022 (USD MILLION)
Table 97 ROW: COMPETENT CELLS MARKET, BY TYPE, 2015–2022 (USD MILLION)
Table 98 ROW: COMPETENT CELLS MARKET, BY APPLICATION, 2015–2022 (USD MILLION)
Table 99 ROW: COMPETENT CELLS MARKET FOR CLONING APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION)
Table 100 ROW: COMPETENT CELLS MARKET FOR OTHER APPLICATIONS, BY TYPE, 2015–2022 (USD MILLION)
Table 101 ROW: COMPETENT CELLS MARKET, BY END USER, 2015–2022 (USD MILLION)
LIST OF FIGURES
Figure 1 GLOBAL COMPETENT CELLS MARKET
Figure 2 RESEARCH DESIGN
Figure 3 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
Figure 4 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
Figure 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
Figure 6 DATA TRIANGULATION METHODOLOGY
Figure 7 COMPETENT CELLS MARKET, BY TYPE, 2017 VS. 2022 (USD MILLION)
Figure 8 COMPETENT CELLS MARKET, BY APPLICATION, 2017 VS. 2022 (USD MILLION)
Figure 9 COMPETENT CELLS MARKET FOR CLONING, 2017 VS. 2022 (USD MILLION)
Figure 10 COMPETENT CELLS MARKET FOR OTHER APPLICATIONS, 2017 VS. 2022 (USD MILLION)
Figure 11 COMPETENT CELLS MARKET, BY END USER, 2017 VS. 2022 (USD MILLION)
Figure 12 GEOGRAPHIC SNAPSHOT OF THE GLOBAL COMPETENT CELLS MARKET (2017–2022)
Figure 13 EMERGING COUNTRIES TO OFFER LUCRATIVE GROWTH OPPORTUNITIES IN THE MARKET
Figure 14 SUBCLONING & ROUTINE CLONING APPLICATIONS SEGMENT TO ACCOUNT FOR THE LARGEST SHARE IN 2017
Figure 15 NORTH AMERICA TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
Figure 16 CLONING SEGMENT WILL CONTINUE TO DOMINATE THE COMPETENT CELLS MARKET DURING THE FORECAST PERIOD
Figure 17 COMPETENT CELLS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES
Figure 18 CHEMICALLY COMPETENT CELLS TO HOLD LARGEST MARKET SHARE IN 2017
Figure 19 COMPETENT CELLS MARKET SEGMENTATION, BY APPLICATION
Figure 20 CLONING—THE LARGEST APPLICATION SEGMENT IN THE COMPETENT CELLS MARKET
Figure 21 SUBCLONING & ROUTINE CLONING SEGMENT TO DOMINATE THE MARKET IN 2017
Figure 22 COMPETENT CELLS MARKET SIZE, BY END USER, 2017 (USD MILLION)
Figure 23 NORTH AMERICA TO DOMINATE THE COMPETENT CELLS MARKET IN 2022
Figure 24 COMPETENT CELLS MARKET IN NORTH AMERICA TO GROW AT THE HIGHEST RATE (2017 TO 2022)
Figure 25 NORTH AMERICA: COMPETENT CELLS MARKET SNAPSHOT
Figure 26 U.S. TO HOLD LARGEST SHARE OF THE NORTH AMERICAN MARKET IN 2017
Figure 27 EUROPE: COMPETENT CELLS MARKET SNAPSHOT
Figure 28 ASIA-PACIFIC COMPETENT CELLS MARKET SNAPSHOT, 2017
Figure 29 JAPAN TO LEAD THE ASIA-PACIFIC COMPETENT CELLS MARKET IN 2017
Figure 30 GLOBAL COMPETENT CELLS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2016
Figure 31 COMPETENT CELLS MARKET (GLOBAL) COMPETITIVE LEADERSHIP MAPPING, 2017
Figure 32 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2016)
Figure 33 MERCK KGAA: COMPANY SNAPSHOT (2016)
Figure 34 TAKARA BIO INC.: COMPANY SNAPSHOT (2016)
Figure 35 BIO-RAD LABORATORIES, INC: COMPANY SNAPSHOT (2016)
Figure 36 AGILENT TECHNOLOGIES INC.: COMPANY SNAPSHOT (2016)
Figure 37 ILLUMINA, INC.: COMPANY SNAPSHOT (2016)
Figure 38 QIAGEN N.V.: COMPANY SNAPSHOT (2016)
Figure 39 GENSCRIPT BIOTECH CORPORATION: COMPANY SNAPSHOT (2016)
Figure 1 GLOBAL COMPETENT CELLS MARKET
Figure 2 RESEARCH DESIGN
Figure 3 MARKET SIZE ESTIMATION METHODOLOGY: BOTTOM-UP APPROACH
Figure 4 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH
Figure 5 BREAKDOWN OF PRIMARY INTERVIEWS: BY COMPANY TYPE, DESIGNATION, AND REGION
Figure 6 DATA TRIANGULATION METHODOLOGY
Figure 7 COMPETENT CELLS MARKET, BY TYPE, 2017 VS. 2022 (USD MILLION)
Figure 8 COMPETENT CELLS MARKET, BY APPLICATION, 2017 VS. 2022 (USD MILLION)
Figure 9 COMPETENT CELLS MARKET FOR CLONING, 2017 VS. 2022 (USD MILLION)
Figure 10 COMPETENT CELLS MARKET FOR OTHER APPLICATIONS, 2017 VS. 2022 (USD MILLION)
Figure 11 COMPETENT CELLS MARKET, BY END USER, 2017 VS. 2022 (USD MILLION)
Figure 12 GEOGRAPHIC SNAPSHOT OF THE GLOBAL COMPETENT CELLS MARKET (2017–2022)
Figure 13 EMERGING COUNTRIES TO OFFER LUCRATIVE GROWTH OPPORTUNITIES IN THE MARKET
Figure 14 SUBCLONING & ROUTINE CLONING APPLICATIONS SEGMENT TO ACCOUNT FOR THE LARGEST SHARE IN 2017
Figure 15 NORTH AMERICA TO REGISTER THE HIGHEST GROWTH RATE DURING THE FORECAST PERIOD
Figure 16 CLONING SEGMENT WILL CONTINUE TO DOMINATE THE COMPETENT CELLS MARKET DURING THE FORECAST PERIOD
Figure 17 COMPETENT CELLS MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, & CHALLENGES
Figure 18 CHEMICALLY COMPETENT CELLS TO HOLD LARGEST MARKET SHARE IN 2017
Figure 19 COMPETENT CELLS MARKET SEGMENTATION, BY APPLICATION
Figure 20 CLONING—THE LARGEST APPLICATION SEGMENT IN THE COMPETENT CELLS MARKET
Figure 21 SUBCLONING & ROUTINE CLONING SEGMENT TO DOMINATE THE MARKET IN 2017
Figure 22 COMPETENT CELLS MARKET SIZE, BY END USER, 2017 (USD MILLION)
Figure 23 NORTH AMERICA TO DOMINATE THE COMPETENT CELLS MARKET IN 2022
Figure 24 COMPETENT CELLS MARKET IN NORTH AMERICA TO GROW AT THE HIGHEST RATE (2017 TO 2022)
Figure 25 NORTH AMERICA: COMPETENT CELLS MARKET SNAPSHOT
Figure 26 U.S. TO HOLD LARGEST SHARE OF THE NORTH AMERICAN MARKET IN 2017
Figure 27 EUROPE: COMPETENT CELLS MARKET SNAPSHOT
Figure 28 ASIA-PACIFIC COMPETENT CELLS MARKET SNAPSHOT, 2017
Figure 29 JAPAN TO LEAD THE ASIA-PACIFIC COMPETENT CELLS MARKET IN 2017
Figure 30 GLOBAL COMPETENT CELLS MARKET SHARE ANALYSIS, BY KEY PLAYER, 2016
Figure 31 COMPETENT CELLS MARKET (GLOBAL) COMPETITIVE LEADERSHIP MAPPING, 2017
Figure 32 THERMO FISHER SCIENTIFIC INC.: COMPANY SNAPSHOT (2016)
Figure 33 MERCK KGAA: COMPANY SNAPSHOT (2016)
Figure 34 TAKARA BIO INC.: COMPANY SNAPSHOT (2016)
Figure 35 BIO-RAD LABORATORIES, INC: COMPANY SNAPSHOT (2016)
Figure 36 AGILENT TECHNOLOGIES INC.: COMPANY SNAPSHOT (2016)
Figure 37 ILLUMINA, INC.: COMPANY SNAPSHOT (2016)
Figure 38 QIAGEN N.V.: COMPANY SNAPSHOT (2016)
Figure 39 GENSCRIPT BIOTECH CORPORATION: COMPANY SNAPSHOT (2016)
